Effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin among nonvalvular atrial fibrillation patients with prior bleeding events

被引：0
|
作者：
Lip, G. Y. H. [1 ]
Keshishian, A. [2 ]
Kang, A. [3 ]
Luo, X. [4 ]
Atreja, N. [3 ]
Zhang, Y. [3 ]
Schuler, P. [3 ]
Jiang, J. [3 ]
Lovett, K. [2 ]
Yuce, H. [5 ]
Deitelzweig, S. [6 ]
机构：
[1] Univ Liverpool, Liverpool, Merseyside, England
[2] STATinMED Res, Ann Arbor, MI USA
[3] Bristol Myers Squibb Co, Lawrenceville, NJ USA
[4] Pfizer Inc, New York, NY USA
[5] CUNY, New York, NY 10021 USA
[6] Ochsner Clin Fdn, New Orleans, LA USA
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：571 / 571
页数：1
相关论文
共 50 条
  • [41] Cost-Effectiveness Analysis of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Thai Patients With Non-Valvular Atrial Fibrillation
    Dilokthornsakul, Piyameth
    Nathisuwan, Surakit
    Krittayaphong, Rungroj
    Chutinet, Aurauma
    Permsuwan, Unchalee
    HEART LUNG AND CIRCULATION, 2020, 29 (03): : 390 - 400
  • [42] Non-vitamin K antagonist oral anticoagulants in cancer patients with atrial fibrillation
    Undas, Anetta
    Drabik, Leszek
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2020, 23 (01): : 10 - 18
  • [43] Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Thrombocytopenia
    Janion-Sadowska, Agnieszka
    Papuga-Szela, Elbieta
    Lukaszuk, Robert
    Chrapek, Magdalena
    Undas, Anetta
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2018, 72 (03) : 153 - 160
  • [44] Cessation of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
    Middeldorp, Melissa E.
    Gupta, Aashray
    Elliott, Adrian
    Kadhim, Kadhim
    Thiyagarajah, Anand
    Gallagher, Celine
    Hendriks, Jeroen
    Linz, Dominik
    Emami, Mehrdad
    Mahajan, Rajiv
    Lau, Dennis
    Sanders, Prashanthan
    HEART, 2021, 107 (12) : 971 - 976
  • [45] The safety and efficacy of non-vitamin K antagonist oral anticoagulants in atrial fibrillation in the elderly
    Patti, Giuseppe
    Cavallari, Ilaria
    Hanon, Olivier
    De Caterina, Raffaele
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 265 : 118 - 124
  • [46] Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation and valvular heart disease
    Li, Hsing-Jung
    Lin, Shin-Yi
    Lin, Fang-Ju
    Hung, Chi-Sheng
    Wang, Chi-Chuan
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (04) : 535 - 542
  • [47] Non-vitamin K antagonist oral anticoagulants (NOAC) in nonvalvular atrial fibrillation - in-group comparison
    Piasecki, Adam
    BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO, 2022, (01):
  • [48] Safety and effectiveness of anticoagulation with non-vitamin K antagonist oral anticoagulants and warfarin in patients on tuberculosis treatment
    Lee, Hyun-Jung
    Kim, Hyung-Kwan
    Kim, Bong-Seong
    Han, Kyung-Do
    Park, Chan Soon
    Rhee, Tae-Min
    Park, Jun-Bean
    Lee, Heesun
    Kim, Yong-Jin
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [49] Safety and effectiveness of anticoagulation with non-vitamin K antagonist oral anticoagulants and warfarin in patients on tuberculosis treatment
    Hyun-Jung Lee
    Hyung-Kwan Kim
    Bong-Seong Kim
    Kyung-Do Han
    Chan Soon Park
    Tae-Min Rhee
    Jun-Bean Park
    Heesun Lee
    Yong-Jin Kim
    Scientific Reports, 13
  • [50] Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study
    Halvorsen, Sigrun
    Johnsen, Soren P.
    Madsen, Morten
    Linder, Marie
    Sulo, Gerhard
    Ghanima, Waleed
    Gislason, Gunnar
    Hohnloser, Stefan H.
    Jenkins, Aaron
    Al-Khalili, Faris
    Tell, Grethe S.
    Ehrenstein, Vera
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2022, 8 (05) : 577 - 587
12345